Conference Coverage

VIDEO: Move beyond BMI to see obesity as a disease


 

REPORTING FROM AACE 2018

The five medications approved for chronic management of obesity all have been shown to be safe and effective in clinical trials. But they have different mechanisms of action, different side effect profiles, and different warnings and precautions, Dr. Garvey noted.

Understanding the pharmacology of all five drugs is important to help a specific patient achieve the best outcomes.

“There’s no drug that can be recommended, in a hierarchical sense, as being better than any others across the board in all patients,” Dr. Garvey explained. “We really need to individualize therapy based on their side effect profile and their types of complications that present with the patient.”

Recommended Reading

MDedge Daily News: Why low-calorie sucralose may fuel weight gain
MDedge Endocrinology
Prior bariatric surgery may lead to IBD
MDedge Endocrinology
VIDEO: Intestinal remodeling contributes to HbA1c drop after Roux-en-Y gastric bypass
MDedge Endocrinology
Being overweight as a child increases the risk of developing diabetes
MDedge Endocrinology
Life and health are not even across the U.S.
MDedge Endocrinology
CVD risk high in individuals who once had metabolically healthy obesity
MDedge Endocrinology
MDedge Daily News: Physician burnout needs more than yoga
MDedge Endocrinology
Sucralose sparks appetite in obese, not lean, individuals
MDedge Endocrinology
VIDEO: BMI helps predict bone fragility in obese patients
MDedge Endocrinology
Trends in teen consumption of sports drinks are up and down
MDedge Endocrinology